asia pacific radiology information systems (ris) Market

The Asia Pacific radiology information system (RIS) market is projected to grow from US$ 191.45 million in 2019 to US$ 375.45 million by 2027; it is expected to grow at a CAGR of 9.0% from 2020 to 2027.

The growth of the Asia Pacific radiology information system (RIS) market attributes to the continuous advancements in diagnostic imaging solutions coupled with rising number of diagnostic procedures and increasing incidences of partnerships and collaborations among the players operating in the market.

The number of active participants and approvals by regulatory agencies is increasing. For instance, in 2019, Philips introduced IntelliSpace Cardiovascular 4.1, a cardiovascular image and information management system, which offers efficient pediatric reporting capabilities. The prevalence of cardiovascular disorders is rising and the launch of software leads to better treatment and diagnosis options. Therefore, the growing number of diagnostic imaging procedures and advancements drives the growth of the Asia Pacific radiology information system (RIS) market.

By product, the integrated RIS segment held the largest share of the Asia Pacific radiology information system (RIS) market in 2019. This segment is also predicted to dominate the market by 2027 owing to the higher demand for these systems. However, the services segment is anticipated to witness growth at a significant rate during the forecast period.

A few major primary and secondary sources referred to while preparing the report of the Asia Pacific radiology information system (RIS) market arthe US Food and Drug Administration (FDA), Therapeutic Goods Administration.